These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 3830071)

  • 21. [Radiation therapy of Graves' ophthalmopathy].
    Kawamura T; Koga S; Anno H; Komai S
    Nihon Igaku Hoshasen Gakkai Zasshi; 1992 Jan; 52(1):78-85. PubMed ID: 1549451
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of the effectiveness and tolerability of intravenous or oral glucocorticoids associated with orbital radiotherapy in the management of severe Graves' ophthalmopathy: results of a prospective, single-blind, randomized study.
    Marcocci C; Bartalena L; Tanda ML; Manetti L; Dell'Unto E; Rocchi R; Barbesino G; Mazzi B; Bartolomei MP; Lepri P; Cartei F; Nardi M; Pinchera A
    J Clin Endocrinol Metab; 2001 Aug; 86(8):3562-7. PubMed ID: 11502779
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Extraocular muscle antibodies and the occurrence of ophthalmopathy in Graves' disease.
    de Bellis A; Perrino S; Coronella C; Sansone D; Ruocco G; Tirelli G; Di Martino S; Conte M; Bellastella G; Wall JR; Bellastella A; Bizzarro A
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):694-8. PubMed ID: 15163332
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Severe Graves' ophthalmopathy after retrobulbar anesthesia for cataract extraction in a patient with mild stable thyroid eye disease.
    Wai DC; Ho SC; Seah LL; Fong KS; Khoo DH
    Thyroid; 2003 Aug; 13(8):823-6. PubMed ID: 14558926
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinical evaluation of radiotherapy for endocrine ophthalmopathy].
    Okada K; Oshitani T; Mieda C; Ogawa K; Maruta T; Ikeda Y; Suematsu T; Hirata Y; Obayashi K; Ishida T
    Nihon Igaku Hoshasen Gakkai Zasshi; 1990 Jun; 50(6):649-54. PubMed ID: 2235315
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical features of Graves' ophthalmopathy in an incidence cohort.
    Bartley GB; Fatourechi V; Kadrmas EF; Jacobsen SJ; Ilstrup DM; Garrity JA; Gorman CA
    Am J Ophthalmol; 1996 Mar; 121(3):284-90. PubMed ID: 8597271
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Radiotherapy for thyroid orbitopathy. Effects on extraocular muscle balance.
    Wilson WB; Prochoda M
    Arch Ophthalmol; 1995 Nov; 113(11):1420-5. PubMed ID: 7487604
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quantitative CT of the orbit in Graves' disease.
    Ozgen A; Alp MN; Ariyürek M; Tütüncü NB; Can I; Günalp I
    Br J Radiol; 1999 Aug; 72(860):757-62. PubMed ID: 10624341
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Orbital scintigraphy with [111In-diethylenetriamine pentaacetic acid-D-phe1]-octreotide predicts the clinical response to corticosteroid therapy in patients with Graves' ophthalmopathy.
    Colao A; Lastoria S; Ferone D; Pivonello R; Macchia PE; Vassallo P; Bonavolonta G; Muto P; Lombardi G; Fenzi G
    J Clin Endocrinol Metab; 1998 Nov; 83(11):3790-4. PubMed ID: 9814448
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A prospective, randomized, double-blind, placebo-controlled study of orbital radiotherapy for Graves' ophthalmopathy.
    Gorman CA; Garrity JA; Fatourechi V; Bahn RS; Petersen IA; Stafford SL; Earle JD; Forbes GS; Kline RW; Bergstralh EJ; Offord KP; Rademacher DM; Stanley NM; Bartley GB
    Ophthalmology; 2001 Sep; 108(9):1523-34. PubMed ID: 11535445
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of steroid pulse therapy with and without orbital radiotherapy on Graves' ophthalmopathy.
    Ohtsuka K; Sato A; Kawaguchi S; Hashimoto M; Suzuki Y
    Am J Ophthalmol; 2003 Mar; 135(3):285-90. PubMed ID: 12614743
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Graves' ophthalmopathy--a clinical review.
    Carter JN
    Aust N Z J Ophthalmol; 1990 Aug; 18(3):239-42. PubMed ID: 2261168
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of Graves' disease and the course of ophthalmopathy.
    Sridama V; DeGroot LJ
    Am J Med; 1989 Jul; 87(1):70-3. PubMed ID: 2741983
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Colour Doppler imaging of the orbital vasculature in Graves' disease with computed tomographic correlation.
    Alp MN; Ozgen A; Can I; Cakar P; Gunalp I
    Br J Ophthalmol; 2000 Sep; 84(9):1027-30. PubMed ID: 10966959
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Graves' ophthalmopathy: I. Simple CT estimates of extraocular muscle volume.
    Hallin ES; Feldon SE
    Br J Ophthalmol; 1988 Sep; 72(9):674-7. PubMed ID: 3179254
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quantitative analysis of extraocular muscle volume and exophthalmos reduction after radiation therapy to treat Graves' ophthalmopathy: A pilot study.
    Kim M; Chang JH; Lee NK
    Eur J Ophthalmol; 2021 Mar; 31(2):340-345. PubMed ID: 31496266
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The current role of radiotherapy in immunogenic exophthalmos].
    Malinverni G; Giordana C; Rosmino C; Mancini A; Sala S
    Radiol Med; 1994 Nov; 88(5):665-9. PubMed ID: 7824786
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A randomized controlled trial of orbital radiotherapy versus sham irradiation in patients with mild Graves' ophthalmopathy.
    Prummel MF; Terwee CB; Gerding MN; Baldeschi L; Mourits MP; Blank L; Dekker FW; Wiersinga WM
    J Clin Endocrinol Metab; 2004 Jan; 89(1):15-20. PubMed ID: 14715820
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Orbital radiotherapy for Graves' ophthalmopathy.
    Bartalena L; Marcocci C; Tanda ML; Rocchi R; Mazzi B; Barbesino G; Pinchera A
    Thyroid; 2002 Mar; 12(3):245-50. PubMed ID: 11952048
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pathological and clinical study of Müller's muscle in Graves' ophthalmopathy.
    Rootman J; Patel S; Berry K; Nugent R
    Can J Ophthalmol; 1987 Feb; 22(1):32-6. PubMed ID: 3815153
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.